The impact of the percent of positive prostate biopsies on prostate cancer-specific mortality for patients with low or favorable intermediate risk disease

Abstract

Purpose We investigated whether pretreatment factors predicted time to prostate cancer–specific mortality (PCSM) after conventional-dose and conformal radiation therapy (CRT).